FindTrial
Sign In

Thoracic epidural anesthesia for percutaneous radiofrequency abalaion of hepatocellular carcinoma

Thoracic epidural anesthesia for percutaneous radiofrequency abalaion of hepatocellular carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002606
Enrollment
223
Registered
2017-12-22
Start date
2017-05-18
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Pusan National University Yangsan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We enrolled physical status 1 to 3 patients (according to American Society of Anesthesiologists criteria), who were = 20 years of age and scheduled to receive percutaneous RFA to treat hepatocellular carninoma.

Exclusion criteria

Exclusion criteria: Exclusion criteria were hypersensitiviey to local anesthetics, infection at the injection site, sepsis, and coagulopathy (derined as an international normalized ratio (INR) > 1.4 or a platelet count < 100,000/ mm3) were excluded from the study.

Design outcomes

Secondary

MeasureTime frame
rate of patients requiring additional analgesics;incidence rate of postoperative nausea and vomiting (PONV);incidence rate of side effects—

Primary

MeasureTime frame
analgesic efficacy using the numeric rating scale (NRS)—

Countries

Korea, Republic of

Contacts

Public ContactEun-Ji Choi

Pusan National University Yangsan Hospital

acej01@naver.com+82-55-360-1422

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026